Top

Current Atherosclerosis Reports

Published in:

10-05-2023 | Positron Emission Tomography

The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations

Authors: Malek Nayfeh, Ahmed Ibrahim Ahmed, Jean Michel Saad, Fares Alahdab, Mouaz Al-Mallah

Published in: Current Atherosclerosis Reports | Issue 7/2023

Abstract

Purpose of Review

Despite single-photon emission computerized tomography (SPECT) being the most used nuclear imaging technique for diagnosis of coronary artery disease (CAD), many now consider positron emission tomography (PET) as a superior modality. This review will focus on the advances of cardiac PET in recent years and its advantages compared to SPECT in diagnosis and prognosis of CAD.

Recent Findings

PET’s higher resolution and enhanced diagnostic accuracy, as well as lower radiation exposure, all help explain the rationale for its wider spread and use. PET also allows for measurement of myocardial blood flow (MBF) and myocardial flow reserve (MFR), which aids in several different clinical scenarios, such as diagnosing multivessel disease or identifying non-responders. PET has also been shown to be useful in diagnosing CAD in various specific populations, such as patients with prior COVID-19 infection, cardiac transplant, and other comorbidities.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639. https://doi.org/10.1161/cir.0000000000001052.CrossRefPubMed

Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. https://doi.org/10.21037/atm.2016.06.33.CrossRefPubMedPubMedCentral

Reeves RA, Halpern EJ, Rao VM. Cardiac imaging trends from 2010 to 2019 in the Medicare population. Radiol Cardiothorac Imaging. 2021;3(5):e210156. https://doi.org/10.1148/ryct.2021210156.CrossRefPubMedPubMedCentral

Slomka P, Berman DS, Alexanderson E, Germano G. The role of PET quantification in cardiovascular imaging. Clin Transl Imaging. 2014;2(4):343–58. https://doi.org/10.1007/s40336-014-0070-2.CrossRefPubMedPubMedCentral

Lin E, Alessio A. What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr. 2009;3(6):403–8. https://doi.org/10.1016/j.jcct.2009.07.003.CrossRefPubMedPubMedCentral

El-Tallawi KC, Aljizeeri A, Nabi F, Al-Mallah MH. Myocardial perfusion imaging using positron emission tomography. Methodist Debakey Cardiovasc J. 2020;16(2):114–21. https://doi.org/10.14797/mdcj-16-2-114.CrossRefPubMedPubMedCentral

Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging. 2009;2(5):412–24. https://doi.org/10.1161/circimaging.109.854893.CrossRefPubMed

Desiderio MC, Lundbye JB, Baker WL, Farrell MB, Jerome SD, Heller GV. Current status of patient radiation exposure of cardiac positron emission tomography and single-photon emission computed tomographic myocardial perfusion imaging. Circ Cardiovasc Imaging. 2018;11(12):e007565. https://doi.org/10.1161/circimaging.118.007565.CrossRefPubMed

Driessen RS, van Diemen PA, Raijmakers PG, Knuuti J, Maaniitty T, Underwood SR, et al. Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study. Eur Heart J. 2022;43(33):3118–28. https://doi.org/10.1093/eurheartj/ehac286.CrossRefPubMedPubMedCentral

10.

Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13(1):24–33. https://doi.org/10.1016/j.nuclcard.2005.12.004.CrossRefPubMed

11.

Marwick TH, Go RT, MacIntyre WJ, Saha GB, Underwood DA. Myocardial perfusion imaging with positron emission tomography and single photon emission computed tomography: frequency and causes of disparate results. Eur Heart J. 1991;12(10):1064–9. https://doi.org/10.1093/oxfordjournals.eurheartj.a059838.CrossRefPubMed

12.

Tamaki N, Yonekura Y, Senda M, Yamashita K, Koide H, Saji H, et al. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography. J Nucl Med. 1988;29(7):1181–8.PubMed

13.

Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2(10):1100–7. https://doi.org/10.1001/jamacardio.2017.2471.CrossRefPubMedPubMedCentral

14.

Ziadi MC. Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis. Cardiovasc Diagn Ther. 2017;7(2):206–18. https://doi.org/10.21037/cdt.2017.04.10.CrossRefPubMedPubMedCentral

15.

Vidula MK, Wiener P, Selvaraj S, Khan MS, Salam UA, Rojulpote C, et al. Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythm. J Nucl Cardiol. 2021;28(3):981–8. https://doi.org/10.1007/s12350-020-02398-5.CrossRefPubMed

16.

Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2(7):846–54. https://doi.org/10.1016/j.jcmg.2009.04.009.CrossRefPubMedPubMedCentral

17.

Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJ, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19(4):670–80. https://doi.org/10.1007/s12350-011-9506-5.CrossRefPubMed

18.

Geltman EM, Henes CG, Senneff MJ, Sobel BE, Bergmann SR. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol. 1990;16(3):586–95. https://doi.org/10.1016/0735-1097(90)90347-r.CrossRefPubMed

19.

Ahmed AI, Al Rifai M, Alahdab F, Saad JM, Han Y, Alfawara MS, et al. Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: a prospective cohort study. Int J Cardiol. 2023;371:465–71. https://doi.org/10.1016/j.ijcard.2022.09.015.CrossRefPubMed

20.

Aljizeeri A, Ahmed AI, Alfaris MA, Ahmed D, Farea J, Elneama A, et al. Myocardial flow reserve and coronary calcification in prognosis of patients with suspected coronary artery disease. JACC Cardiovasc Imaging. 2021;14(12):2443–52. https://doi.org/10.1016/j.jcmg.2021.01.024.CrossRefPubMed

21.

Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5(6):700–7. https://doi.org/10.1161/circimaging.112.978270.CrossRefPubMed

22.

Flotats A, Bravo PE, Fukushima K, Chaudhry MA, Merrill J, Bengel FM. Rb PET myocardial perfusion imaging is superior to mTc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging. 2012;39(8):1233–9. https://doi.org/10.1007/s00259-012-2140-x.CrossRefPubMed

23.

Chow BJW, Dorbala S, Carli MFD, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovascular Imaging. 2014;7(3):278–87. https://doi.org/10.1016/j.jcmg.2013.12.008.CrossRefPubMed

24.

Harnett DT, Hazra S, Maze R, Mc Ardle BA, Alenazy A, Simard T, et al. Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity. J Nucl Cardiol. 2019;26(1):275–83. https://doi.org/10.1007/s12350-017-0855-6.CrossRefPubMed

25.

Jang JJ, Bhapkar M, Coles A, Vemulapalli S, Fordyce CB, Lee KL, et al. Predictive model for high-risk coronary artery disease. Circ Cardiovasc Imaging. 2019;12(2):e007940. https://doi.org/10.1161/circimaging.118.007940.CrossRefPubMedPubMedCentral

26.

Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014;55(2):248–55. https://doi.org/10.2967/jnumed.113.121442.CrossRefPubMed

27.

Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226. https://doi.org/10.1007/s12350-016-0522-3.CrossRefPubMed

28.

Yokota S, Ottervanger JP, Mouden M, Timmer JR, Knollema S, Jager PL. Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging. J Nucl Cardiol. 2014;21(2):284–90. https://doi.org/10.1007/s12350-013-9837-5.CrossRefPubMed

29.

Bravo PE, Di Carli MF, Dorbala S. Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Fail Rev. 2017;22(4):455–64. https://doi.org/10.1007/s10741-017-9628-1.CrossRefPubMedPubMedCentral

30.

Patriki D, von Felten E, Bakula A, Giannopoulos AA, Kamani CH, Schwyzer M, et al. Splenic switch-off as a predictor for coronary adenosine response: validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner. J Cardiovasc Magn Reson. 2021;23(1):3. https://doi.org/10.1186/s12968-020-00696-y.CrossRefPubMedPubMedCentral

31.

Saad JM, Ahmed AI, Han Y, El Nihum LI, Alahdab F, Nabi F, et al. Splenic switch-off in regadenoson 82Rb-PET myocardial perfusion imaging: assessment of clinical utility. J Nucl Cardiol. 2023. https://doi.org/10.1007/s12350-022-03158-3.CrossRefPubMed

32.

Patel KK, Spertus JA, Chan PS, Sperry BW, Al Badarin F, Kennedy KF, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization. Eur Heart J. 2020;41(6):759–68. https://doi.org/10.1093/eurheartj/ehz389.CrossRefPubMed

33.

BaireyMerz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135(11):1075–92. https://doi.org/10.1161/circulationaha.116.024534.CrossRef

34.

Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. 2022;19(5):332–41. https://doi.org/10.1038/s41569-021-00631-3.CrossRefPubMed

35.

Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–8. https://doi.org/10.1111/jce.14479.CrossRefPubMedPubMedCentral

36.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3.CrossRefPubMedPubMedCentral

37.

Wang J, Saguner AM, An J, Ning Y, Yan Y, Li G. Dysfunctional coagulation in COVID-19: from cell to bedside. Adv Ther. 2020;37(7):3033–9. https://doi.org/10.1007/s12325-020-01399-7.CrossRefPubMedPubMedCentral

38.

Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–90. https://doi.org/10.1038/s41591-022-01689-3.CrossRefPubMedPubMedCentral

39.

Ahmed AI, Saad JM, Han Y, Alahdab F, Malahfji M, Nabi F, et al. Coronary microvascular health in patients with prior COVID-19 infection. JACC Cardiovasc Imaging. 2022;15(12):2153–5. https://doi.org/10.1016/j.jcmg.2022.07.006.CrossRefPubMedPubMedCentral

40.

Weber B, Parks S, Huck DM, Kim A, Bay C, Brown JM, et al. Prior SARS-CoV-2 infection is associated with coronary vasomotor dysfunction as assessed by coronary flow reserve from cardiac positron emission tomography. J Am Heart Assoc. 2022;11(20):e025844. https://doi.org/10.1161/jaha.122.025844.CrossRefPubMedPubMedCentral

41.

Taylor DO, Edwards LB, Boucek MM, Trulock EP, Waltz DA, Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report–2006. J Heart Lung Transplant. 2006;25(8):869–79. https://doi.org/10.1016/j.healun.2006.05.002.CrossRefPubMed

42.

Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56. https://doi.org/10.1016/j.healun.2010.05.034.CrossRefPubMed

43.

Chih S, Chong AY, Erthal F, deKemp RA, Davies RA, Stadnick E, et al. PET Assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy. J Am Coll Cardiol. 2018;71(13):1444–56. https://doi.org/10.1016/j.jacc.2018.01.062.CrossRefPubMed

44.

Konerman MC, Lazarus JJ, Weinberg RL, Shah RV, Ghannam M, Hummel SL, et al. Reduced myocardial flow reserve by positron emission tomography predicts cardiovascular events after cardiac transplantation. Circ Heart Fail. 2018;11(6):e004473. https://doi.org/10.1161/circheartfailure.117.004473.CrossRefPubMedPubMedCentral

45.

Miller RJH, Manabe O, Tamarappoo B, Hayes S, Friedman JD, Slomka PJ, et al. Comparative prognostic and diagnostic value of myocardial blood flow and myocardial flow reserve after cardiac transplantation. J Nucl Med. 2020;61(2):249–55. https://doi.org/10.2967/jnumed.119.229625.CrossRefPubMed

46.

Feher A, Srivastava A, Quail MA, Boutagy NE, Khanna P, Wilson L, et al. Serial assessment of coronary flow reserve by rubidium-82 positron emission tomography predicts mortality in heart transplant recipients. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):109–20. https://doi.org/10.1016/j.jcmg.2018.08.025.CrossRefPubMed

47.

Ajluni SC Jr, Mously H, Chami T, Hajjari J, Stout A, Zacharias M, et al. Non-invasive imaging in the evaluation of cardiac allograft vasculopathy in heart transplantation: a systematic review. Curr Probl Cardiol. 2022;47(8):101103. https://doi.org/10.1016/j.cpcardiol.2022.101103.CrossRefPubMed

48.

Clerkin KJ, Topkara VK, Farr MA, Jain R, Colombo PC, Restaino S, et al. Noninvasive physiologic assessment of cardiac allograft vasculopathy is prognostic for post-transplant events. J Am Coll Cardiol. 2022;80(17):1617–28. https://doi.org/10.1016/j.jacc.2022.08.751.CrossRefPubMed

49.

Poothullil JM. Diabetes and decline in heart disease mortality. JAMA. 1999;282(12):1132-. doi: 10–1001/pubs.JAMA-ISSN-0098–7484–282–12-jbk0922.

50.

Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41(8):1387–93. https://doi.org/10.1016/s0735-1097(03)00166-9.CrossRefPubMed

51.

Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126(15):1858–68. https://doi.org/10.1161/circulationaha.112.120402.CrossRefPubMedPubMedCentral

52.

Assante R, Mainolfi CG, Zampella E, Gaudieri V, Nappi C, Mannarino T, et al. Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging. J Nucl Cardiol. 2021;28(4):1222–33. https://doi.org/10.1007/s12350-021-02533-w.CrossRefPubMedPubMedCentral

Title: The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations
Authors: Malek Nayfeh
Ahmed Ibrahim Ahmed
Jean Michel Saad
Fares Alahdab
Mouaz Al-Mallah
Publication date: 10-05-2023
Publisher: Springer US
Keyword: Positron Emission Tomography
Published in: Current Atherosclerosis Reports / Issue 7/2023
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-023-01107-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Please log in to get access to this content

Other articles of this Issue 7/2023

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

The Pandemic of Coronary Heart Disease in South Asia: What Clinicians Need to Know

Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence

Childhood Obesity and Cardiovascular Disease Risk

What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage